They've deliberately reduced their marketing spend as they identified that marketing wasn't the way forward to sufficiently boost sales without needing significant funding and dilution.
The OTC clearance in the US means we are a step closer to finding a big licensing partner - which is the main game now to unlocking value.
That's how i see it.
